Market Herald logo

Subscribe

Be the first with the news that moves the market
  • ARway (ARWY) has signed five new deals for its software development kit (SDK)
  • New clients include the Vellore Institute of Technology, Wicked Interactive Storytelling, Intron, DQ Turkey and LeLaboDigital
  • The deals, which range from $9,000-$15,000, continue the wave of demand since the SDK was released on January 31, 2023
  • CEO Evan Gappelberg spoke with Coreena Robertson about the news
  • ARway is an artificial intelligence and augmented reality navigation platform for the real-world metaverse
  • ARway (ARWY) opened unchanged trading at $1.02 per share

ARway (ARWY) has signed five new deals for its software development kit (SDK).

New client summary

  • Vellore Institute of Technology, which will employ campus wayfinding in an Indian university
  • Wicked Interactive Storytelling, which will use AR contextual content for engaging tourists on holiday sites
  • Intron, based in MENA (Middle East and North Africa), which is using ARway in universities for wayfinding and guided tours
  • DQ Turkey, based in MENA, which is using ARway in airports and universities for wayfinding and guided tours
  • LeLaboDigital, an SDK Partner and software development agency in Lebanon, which is keen on adding AR wayfinding to its service offerings

The deals, which range from $9,000-$15,000, continue the wave of demand from resellers, enterprise corporations and brands since the SDK was released on January 31, 2023.

ARway’s SDK contains code libraries and API information for developers to build white label and private label mobile apps on iOs and Android. Pricing is available in three tiers: 1) digital marketing agencies, content creators, and mobile app developers, 2) enterprise accounts, and 3) educational institutions.

CEO Evan Gappelberg spoke with Coreena Robertson about the news.

ARway is an artificial intelligence and augmented reality navigation platform for the real-world metaverse.

ARway (ARWY) opened unchanged trading at $1.02 per share.

This is sponsored content, please see full disclaimer here.


More From The Market Herald
Neuralink - Founder, Elon Musk.

" Neuralink brain chips approved for human trials

Elon Musk’s Neuralink, a brain implant firm, has received regulatory approval for U.S. human trials.

" Marvell stock spikes 30 per cent on Q1 news  

Marvell Technology (NASDAQ:MRVL) shares rose more than 30 per cent Friday.

" The real estate photography firm that grew 25 per cent in  Q2 2023

Urbanimmersive (TSVV:UI) reported financial results and presents business highlights for its Q2 ended March 31, 2023.